Furthermore, syringin exhibits strong anti-osteoporosis effects in ovariectomized mice, with its underlying molecular mechanism possibly being the NF-κB and human phosphoinositide-3 kinase/protein kinase B (PI3K/AKT) signaling pathways (Liu et al., 2018). This evidence concerns the gene AKT1 and osteoporosis.